cadila healthcare ltd.
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for cadila healthcare ltd. from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 2 transactions, with a transaction quantity of 195.27 and a transaction weight of 195.27.
- Year Transactions Quantity Weight
- 2025 43 8851.44 8672.97
- 2026 2 195.27 195.27
Bill of lading data
< 1/15 >- Trade date 2026/01/05 B/L No. 92003004317828
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 109.35kg Amount 13556.48
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01256048, CODIGO OEA OE0355, DECLARACION 1 DE 2, // FACTURA:2107423866, FECHA:27-12-2025 PEDIDO: 4700063104 PRODUCTO: Expand
- Trade date 2026/01/05 B/L No. 92003004317835
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 85.92kg Amount 13964.9
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01256048, CODIGO OEA OE0355, DECLARACION 2 DE 2, // FACTURA:2107423865, FECHA:27-12-2025 PEDIDO: 4700062977 PRODUCTO: Expand
- Trade date 2025/12/24 B/L No. 92003008509517
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 66.23kg Amount 18014.54
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01255884, CODIGO OEA OE0355PEDIDO 4700063069, DECLARACION 1 DE 1, // FACTURA:2107423795, FECHA:13-12-2025 PRODUCTO: M Expand
- Trade date 2025/12/17 B/L No. 92003000063952
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 140.19kg Amount 29320
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01255788, CODIGO OEA OE0355, DECLARACION 1 DE 4, // FACTURA:2107423786, FECHA:10-12-2025 PEDIDO: 4700062827 PRODUCTO: Expand
- Trade date 2025/12/17 B/L No. 92003000064635
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 100.7kg Amount 21039.55
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01255788, CODIGO OEA OE0355, DECLARACION 2 DE 4, // FACTURA:2107423785, FECHA:10-12-2025 PEDIDO: 4700062908 PRODUCTO: Expand
- Trade date 2025/12/17 B/L No. 92003000064642
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 131.45kg Amount 21581.6
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01255788, CODIGO OEA OE0355, DECLARACION 3 DE 4, // FACTURA:2107423787, FECHA:10-12-2025 PEDIDO: 4700062896 PRODUCTO: Expand
- Trade date 2025/12/17 B/L No. 92003000064651
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 74.97kg Amount 9317.12
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01255788, CODIGO OEA OE0355, DECLARACION 4 DE 4, // FACTURA:2107423788, FECHA:10-12-2025 PEDIDO: 470003068 PRODUCTO: Expand
- Trade date 2025/12/15 B/L No. 92003009916209
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 124.15kg Amount 22295.3
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01255586, CODIGO OEA OE0355PEDIDO 4700062907, DECLARACION 1 DE 1, // FACTURA:2107423748, FECHA:26-11-2025 PRODUCTO: M Expand
- Trade date 2025/12/04 B/L No. 92003009631359
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 181.49kg Amount 17318.9
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01255503, CODIGO OEA OE0355, DECLARACION 1 DE 2, // FACTURA:2107423689, FECHA:12-11-2025 PEDIDO 4700062787 PRODUCTO: Expand
- Trade date 2025/12/04 B/L No. 92003009631373
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 39.4kg Amount 2515.23
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01255503, CODIGO OEA OE0355, DECLARACION 2 DE 2, // FACTURA:2107423688, FECHA:12-11-2025 PEDIDO 4700062725 PRODUCTO: Expand
- Trade date 2025/11/06 B/L No. 92003008696175
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 324.2kg Amount 7769.42
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01254960, CODIGO OEA OE0355, DECLARACION 1 DE 2, // FACTURA:2107423593, FECHA:08-10-2025 PEDIDO:4700062724 PRODUCTO: MEDICAMENTO DE USO HUMANO, ZYRISP Y 1 TABLETAS RECUBIERTAS, NOMBRE COMERCIAL: ZYRISP Y 1 TABLETAS RECUBIERTAS, PRINCIPIO ACTIVO: RISPERIDONA, CONCENTRACION: 1 MG, INDICACIONES TERAPEUTICAS: ALTERNATIVA EN LOS TRATAMIENTOSDE ESQUIZOFRENIA AGUDA Y CRONICA. MONOTERAPIA EN DESORDEN BIPOLAR. TRATAMIENTO DE AGITACION, AGRESION O SINTOMAS SICÓTICOS EN PACIENTES CON DEMENCIA MODERADA A GRAVE DETIPO ALZHEIMER. TRATAMIENTO DE LOS DESIRDENES DE LA CONDUCTA EN NIÑOS, ADOLESCENTES Y ADULTOS CON RETARDO MENTAL. COADYUVANTE A CORTO Y MEDIANO PLAZO EN EL MANEJO DE LA ENFERMEDADDE AUTISMO., FORMA FARMACEUTICA: TA - TABLETA, TIPO DE EMPAQUE: 1R1027411007100 - RISPERIDONA 1,0000 MG TABLETAS DE LIBERACION NO MODIFICADA ORAL (ZYRISP) TABLETA 1,0000U / CAJA X 100 - CAJA CON 10 BLISTER DE ALUMINIO- PVC/PVDC POR 10 TABLETAS C/U, CAJA CON 3 BLISTER DE ALUMINIO- PVC/PVDC POR 10 TABLETAS C/U, MUESTRA MEDICA-CAJACON 3 Expand
- Trade date 2025/11/06 B/L No. 92003008696182
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 67.01kg Amount 18199.37
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01254960, CODIGO OEA OE0355, DECLARACION 2 DE 2, // FACTURA:2107423594, FECHA:08-10-2025 PEDIDO: 4700062895 PRODUCTO: MEDICAMENTO DE USO HUMANO, IVAZYD Y 7.5, NOMBRE COMERCIAL: IVAZYD Y 7.5, PRINCIPIO ACTIVO: CLORHIDRATO DE IVABRADINA 8,085 MG EQUIVALENTE A IVABRADINA, CONCENTRACION: 7,5 MG, INDICACIONES TERAPEUTICAS: TRATAMIENTO SINTOMATICO DE LA ANGINA DE PECHO CRONICA ESTABLE. IVABRADINA ESTA INDICADA EN EL TRATAMIENTO SINTOMATICO DE LA ANGINA DE PECHO CRONICA ESTABLE EN ADULTOS CON ENFERMEDAD CORONARIA CON RITMO SINUSAL NORMAL Y FRECUENCIA CARDIACA . 70 LPM. IVABRADINA ESTA INDICADA: - EN ADULTOS QUE PRESENTAN INTOLERANCIA O UNA CONTRAINDICACION AL USO DE BETA-BLOQUEANTES. -O EN ASOCIACION CON BETA-BLOQUEANTES EN PACIENTES NO CONTROLADOS ADECUADAMENTE CON UNA DOSIS OPTIMA DE BETA-BLOQUEANTE. TRATAMIENTO DE LA INSUFICIENCIA CARDIACA CRONICA IVABRADINA ESTA INDICADA EN LA INSUFICIENCIA CARDIACA CRONICA DE CLASE II-IV DE LA NYHA CON DISFUNCION SISTOLICA, EN PACIENTES EN RITMO SINUSAL Y CUYA FRECUENCIACAR Expand
- Trade date 2025/11/01 B/L No. ——
- Suppliers cadila healthcare ltd. Buyers nutriex importacao e exportacao de produtos nutricionai
- POLs —— PODs anapolis
- Supply area India Purchas area Brazil
- Weight 1000kg Amount 13000
- Hs code 29333946 Product tags insumos,nitro,amidas,tria,pro,hetero,vame,fabrica,mico,compost,tura,tos,dos,sico,bora,nio
- Product description COMPOSTOS HETEROCíCLICOS, EXCLUSIVAMENTE DE HETERO-áTOMO(S) DE AZOTO (NITROGéNIO)|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS QUíMICOS BáSICOS|COMPOSTOS HETEROCICLICOS, SEUS SAIS E SULFONAMIDAS Expand
- Trade date 2025/10/17 B/L No. 92003008140377
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 231.66kg Amount 39370
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01254439, CODIGO OEA OE0355, DECLARACION 1 DE 2, // FACTURA:2107423528, FECHA:17-09-2025 PEDIDO: 4700062735 PRODUCTO: Expand
- Trade date 2025/10/17 B/L No. 92003008140384
- Suppliers cadila healthcare ltd. Buyers laboratorios la sante c.a.
- POLs —— PODs bogota
- Supply area India Purchas area Colombia
- Weight 126.09kg Amount 15407
- Hs code 3004902900 Product tags equipped with fixed dose drug
- Product description DO:01254439, CODIGO OEA OE0355, DECLARACION 2 DE 2, // FACTURA:2107423523, FECHA:17-09-2025 PEDIDO: 4700062829 PRODUCTO: Expand
Partners
Total 1350- Rank Company Transactions Per Detail
- 1 eversana life science services llc united statesbuyer,they trade on 2023-01-26 22938 19.57% >
- 2 dohmen life sciences services llc united statesbuyer,they trade on 2019-08-19 19275 16.44% >
- 3 sunshine heathcare lanka ltd. sri lankabuyer,they trade on 2023-12-18 8730 7.45% >
- 4 centre specialities pharmaceutiques francebuyer,they trade on 2022-05-31 4451 3.8% >
- 5 zydus nikkho farmaceutical ltda. brazilbuyer,they trade on 2025-06-01 4311 3.68% > +View All
Products
Total 164- Products Transactions Per Detail
-
tablet
58 19.59% > -
equipped with fixed dose drug
31 10.47% > -
heterocyclic compound
26 8.78% > -
pharm
26 8.78% > -
ah
20 6.76% >
+View All
Hscode rank
Total 802- HSCode Name Transactions Per Detail
- HS 30049090 95 32.09% >
- HS 3004902900 30 10.14% >
- HS 30049099 25 8.45% >
- HS 29339900 19 6.42% >
- HS 29339949900 9 3.04% > +View All
Trading Area
Total 124- Area Transactions Per Detail
- united states 49849 41.98% >
- sri lanka 16736 14.1% >
- brazil 5851 4.93% >
- france 4947 4.17% >
- nepal 3881 3.27% > +View All
Port statistics
Total 88- Port Name Transactions Per Detail
- mundra 26405 22.24% >
- sahar air cargo acc inbom4 16395 13.81% >
- nhava sheva sea innsa1 9941 8.37% >
- delhi 6568 5.53% >
- thar dry port icd ahmedabad gujarat icd insau6 6324 5.33% > +View All
cadila healthcare ltd. is india Buyer&Supplier,
and primarily engages in the import and export business of products such as tablet，equipped with fixed dose drug，heterocyclic compound.
According to the 52wmb.com global trade database, as of 2026-01-05, the company has completed 181196 international trades,
with its main trading regions covering united states，sri lanka,brazil etc.
The core products include HS30049090，HS3004902900，HS30049099 etc,
often transported via mundra，port sahar air cargo acc inbom4, port nhava sheva sea innsa1 etc,
and its main trading partners are eversana life science services llc，dohmen life sciences services llc，sunshine heathcare lanka ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on cadila healthcare ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool